Alexander Nowak
Stock Analyst at Craig-Hallum
(2.78)
# 1,617
Out of 5,182 analysts
46
Total ratings
47.37%
Success rate
7.7%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BVS Bioventus | Maintains: Buy | $15 → $16 | $9.78 | +63.60% | 7 | Mar 6, 2026 | |
| CELC Celcuity | Maintains: Buy | $96 → $108 | $117.50 | -8.09% | 3 | Nov 13, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $7.62 | +188.71% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $202.88 | -22.61% | 4 | Nov 13, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $11.46 | +397.38% | 6 | Sep 5, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $20.46 | -26.69% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $6.17 | +29.66% | 4 | Apr 24, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $1.25 | +1,340.00% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $20.65 | +142.13% | 2 | Jun 13, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $280 → $160 | $7.10 | +2,153.52% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.76 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $1.93 | +469.95% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $54.10 | +103.33% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $7.06 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $0.89 | +33,532.29% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $10.07 | +178.05% | 1 | Aug 31, 2020 |
Bioventus
Mar 6, 2026
Maintains: Buy
Price Target: $15 → $16
Current: $9.78
Upside: +63.60%
Celcuity
Nov 13, 2025
Maintains: Buy
Price Target: $96 → $108
Current: $117.50
Upside: -8.09%
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $7.62
Upside: +188.71%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $202.88
Upside: -22.61%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $11.46
Upside: +397.38%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $20.46
Upside: -26.69%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $6.17
Upside: +29.66%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $1.25
Upside: +1,340.00%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $20.65
Upside: +142.13%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $280 → $160
Current: $7.10
Upside: +2,153.52%
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $4.76
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $1.93
Upside: +469.95%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $54.10
Upside: +103.33%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $7.06
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $0.89
Upside: +33,532.29%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $10.07
Upside: +178.05%